-
Expanding Lung Cancer Surgery Market: Promising Growth Opportunities and Market Share Projections to 2027
28 Mar 2023 13:56 GMT
… lung cancer.
Diagnosing lung cancer … lung cancer, which is contributing to the growing demand for lung cancer surgery. Additionally, genetic … lung cancer, further driving the growth of the lung cancer … -2027 ššš©šØš«š šš¢š š”š„š¢š š”šš¬
Lung cancer is a major public …
-
Living With Stage 4 Lung Cancer: Survival Rates, Treatments, Emotional Support, and More
28 Mar 2023 11:20 GMT
… has spread, whether certain gene mutations feed the cancer, … your tumor contains certain gene mutations, according to the … lung cancer cells. Some of these treatments target mutations in the following genes … If a personās lung tumor cells contain high levels …
-
Lantern Pharma Announces First Patient Dosed in the Phase 2 Study, Harmonicā¢, for LP-300 in Never Smokers with Advanced Non-Small Cell Lung Cancer
28 Mar 2023 12:15 GMT
… lung cancer (NSCLC).
"Never-smokers with non-small cell lung cancer … genetic mutations in a family of cancer-promoting genes … interacting in the TK gene pathways, interrupting their activity … 15-20% of all lung cancer patients, representing an approximate …
-
Amoy Diagnostics PLC Panel Gets Approval in Japan as CDx for Retevmo in Non-Small Cell Lung Cancer
27 Mar 2023 16:45 GMT
… ) has approved the AmoyDxĀ Pan Lung Cancer PCR Panel as a companion … Ā fusion-positive non-small cell lung cancer.
The AmoyDxĀ PLC panel uses … activation alterations in 11 driver genes ā EGFR, ALK, ROS1, KRAS, BRAF …
-
AmoyDxĀ® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
27 Mar 2023 06:15 GMT
… fusion-positive non-small cell lung cancer ("NSCLC"), … NTRK2/ NTRK3 genes) when all genes on the panel are … EGFR gene mutations, ALK fusion gene, ROS1 fusion gene, BRAF gene mutations, … for genetic testing based on cutting-edge gene analysis …
-
AmoyDxĀ® Pan Lung Cancer PCR PanelĀ Approved in Japan as a Companion DiagnosticĀ for selpercatinib RET fusion positive NSCLC
27 Mar 2023 05:00 GMT
… -positive non-small cell lung cancer (āNSCLCā), for selpercatinib … NTRK2/ NTRK3 genes) when all genes on the panel are … EGFR gene mutations, ALK fusion gene, ROS1 fusion gene, BRAF gene mutations, … for genetic testing based on cutting-edge gene analysis …
-
Global Lung Cancer Diagnostics Strategic Analysis Report 2023: Market to Reach $4.7 Billion by 2030 - Increasing Prevalence and Incidence of Lung Cancer to Push the Demand for Early Diagnoses
24 Mar 2023 03:30 GMT
… Lung Cancer Takes Precedence, Driving the Demand for Lung Cancer Diagnostics
Non-small Cell Lung Cancer … Roche AG
Illumina Inc.
Myriad Genetics Inc.
NanoString Technologies
NeoGenomics Laboratories …
-
Immutep Announces Abstract Accepted for Mini Oral Presentation at ESMOās European Lung Cancer Congress 2023
23 Mar 2023 12:00 GMT
… -X refractory non-small cell lung cancer (NSCLC) patients has been accepted … presentation at ESMOās European Lung Cancer Congress (ELCC) 2023 taking place … therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), and our …
-
Role of Systemic Immunoinflammation Landscape in the Overall Survival of Patients with Leptomeningeal Metastases from Lung Cancer
23 Mar 2023 11:53 GMT
… mortality and morbidity following lung cancer worldwide, leptomeningeal metastases … lung cancer,2 mainly involving improved acknowledgment of genetic … al. Identifying predictive gene expression and signature … to metastatic progression. Genes Dev. 2018;32 …
-
BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1 Trial for SHP2 Inhibitor BBP-398 in Combination with Bristol Myers Squibbās OPDIVOĀ® (nivolumab)
23 Mar 2023 11:30 GMT
… KRAS-mutated non-small cell lung cancer (NSCLC) and other … biopharmaceutical company focused on genetic diseases and cancers, today … patient with non-small cell lung cancer (NSCLC) has been … such as non-small cell lung cancer, colorectal and pancreatic cancer …
About
© 1995-2023